Status:
SUSPENDED
Relapse Prevention and Changing Habits in Anorexia Nervosa
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
Columbia University
Brown University
Conditions:
Anorexia Nervosa
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the curren...
Detailed Description
While many approaches to reducing relapse after hospital care have been tried, there is little information about which treatment elements confer benefit. This trial, Relapse Prevention and Changing Ha...
Eligibility Criteria
Inclusion
- Diagnosis of Anorexia Nervosa at hospital admission
- Medically Stable
- Internet capability with videoconferencing
- Weight restored (BMI \> 19 kg/m2) at New York State Psychiatric Institute
Exclusion
- Current substance use or other comorbid disorder requiring specialized treatment
- Pregnancy
- Imminent risk of suicide
- Serious medical illness
- Daily psychotropic medication other than antidepressants (medications that are known effect weight are exclusionary, i.e. stimulants, olanzapine, mirtazapine)
- Participation in outside psychotherapy or structured treatment program (support groups will be allowed). Individuals who are discharged on medications would need to have a non-study psychiatrist.
Key Trial Info
Start Date :
June 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04810624
Start Date
June 21 2021
End Date
January 30 2026
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032